Name | Aclaris Therapeutics Inc |
---|---|
ISIN | US00461U1051 |
Country | USA |
Currency | USD |
Exchange | NASDAQ |
LEI | 5493000B2LQ9QTW1DF52 |
Who is buying and selling ACRS shares/equities?
Date | <ETF ISIN/Name | Action | Num Shares Bought/Sold | Book Value of Trade |
---|---|---|---|---|
2024-11-18 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -1,800 @3.14001 | -5,652 |
2024-11-18 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -1,800 @3.14001 | -5,652 |
2024-11-08 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -120 @2.64001 | -317 |
2024-11-08 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -120 @2.64001 | -317 |
2024-10-21 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | SELL | -120 @1.21001 | -145 |
2024-10-21 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | SELL | -120 @1.21001 | -145 |